126 related articles for article (PubMed ID: 36778825)
1. Mirogabalin, a selective gabapentinoid for managing neuropathic pain-A curtain raiser.
Nair A
J Anaesthesiol Clin Pharmacol; 2022; 38(4):691-692. PubMed ID: 36778825
[No Abstract] [Full Text] [Related]
2. Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence.
Chen EY; Beutler SS; Kaye AD; Edinoff AN; Khademi SH; Stoltz AE; Rueb NR; Cornett EM; Suh WJ
Anesth Pain Med; 2021 Dec; 11(6):e121402. PubMed ID: 35291398
[TBL] [Abstract][Full Text] [Related]
3. Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain.
Zajączkowska R; Rojewska E; Ciechanowska A; Pawlik K; Ciapała K; Kocot-Kępska M; Makuch W; Wordliczek J; Mika J
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056145
[TBL] [Abstract][Full Text] [Related]
4. Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain.
Zajączkowska R; Pawlik K; Ciapała K; Piotrowska A; Ciechanowska A; Rojewska E; Kocot-Kępska M; Makuch W; Wordliczek J; Mika J
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513935
[TBL] [Abstract][Full Text] [Related]
5. Mirogabalin activates the descending noradrenergic system by binding to the α
Oyama M; Watanabe S; Iwai T; Tanabe M
J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
[TBL] [Abstract][Full Text] [Related]
6. Mirogabalin besylate in the treatment of neuropathic pain.
Burgess J; Javed S; Frank B; Malik RA; Alam U
Drugs Today (Barc); 2020 Feb; 56(2):135-149. PubMed ID: 32163529
[TBL] [Abstract][Full Text] [Related]
7. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation.
Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y
Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339
[TBL] [Abstract][Full Text] [Related]
8. Recognition Mechanism of a Novel Gabapentinoid Drug, Mirogabalin, for Recombinant Human α
Kozai D; Numoto N; Nishikawa K; Kamegawa A; Kawasaki S; Hiroaki Y; Irie K; Oshima A; Hanzawa H; Shimada K; Kitano Y; Fujiyoshi Y
J Mol Biol; 2023 May; 435(10):168049. PubMed ID: 36933823
[TBL] [Abstract][Full Text] [Related]
9. Mirogabalin treatment of postoperative neuropathic pain after thoracic surgery: study protocol for a multicenter, randomized, open-label, parallel-group, interventional trial.
Doi R; Miyazaki T; Tsuchiya T; Matsumoto K; Tomoshige K; Machino R; Mizoguchi S; Matsumoto T; Yamaguchi K; Takatsuna H; Shiosakai K; Nagayasu T
J Thorac Dis; 2021 Oct; 13(10):6062-6070. PubMed ID: 34795952
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia.
Ushida T; Katayama Y; Hiasa Y; Nishihara M; Tajima F; Katoh S; Tanaka H; Maeda T; Furusawa K; Kakehi Y; Kikumori K; Kuroha M
Pain Ther; 2023 Aug; 12(4):963-978. PubMed ID: 37115464
[TBL] [Abstract][Full Text] [Related]
11. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study.
Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T
J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647
[TBL] [Abstract][Full Text] [Related]
12. Mirogabalin-A Novel Selective Ligand for the α2δ Calcium Channel Subunit.
Zajączkowska R; Mika J; Leppert W; Kocot-Kępska M; Malec-Milewska M; Wordliczek J
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572689
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin.
Yamanaka T; Takeshita K; Mochizuki T; Inoue H; Akiyama T
Spine Surg Relat Res; 2023 Mar; 7(2):136-141. PubMed ID: 37041868
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the usefulness of mirogabalin for neuropathic pain: a single-institution retrospective study.
Kanbayashi Y; Amaya F; Ikoma K; Ueno H; Tabuchi Y; Ishikawa T; Takayama K; Taguchi T
Pharmazie; 2020 Nov; 75(11):602-605. PubMed ID: 33239138
[TBL] [Abstract][Full Text] [Related]
15. Mirogabalin: could it be the next generation gabapentin or pregabalin?
Kim JY; Abdi S; Huh B; Kim KH
Korean J Pain; 2021 Jan; 34(1):4-18. PubMed ID: 33380563
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.
Kato J; Baba M; Kuroha M; Kakehi Y; Murayama E; Wasaki Y; Ohwada S
Clin Ther; 2021 May; 43(5):822-835.e16. PubMed ID: 34059327
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids.
Tang H; Lu J; Duan Y; Li D
Mediators Inflamm; 2023; 2023():4893436. PubMed ID: 37152369
[TBL] [Abstract][Full Text] [Related]
18. Analgesic characteristics of a newly developed α
Komatsu S; Nakamura S; Nonaka T; Yamada T; Yamamoto T
Mol Pain; 2021; 17():17448069211052167. PubMed ID: 34823399
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study.
Nikaido T; Takatsuna H; Tabata S; Shiosakai K; Nakatani T; Konno SI
Pain Ther; 2022 Dec; 11(4):1195-1214. PubMed ID: 35857196
[TBL] [Abstract][Full Text] [Related]
20. Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study).
Kimura Y; Yamaguchi S; Suzuki T; Kato J; Chiba S; Hirakawa N; Yamaguchi K; Tanabe Y; Takatsuna H; Kenyoshi Y; Shiosakai K; Sakai M; Iseki M
Pain Ther; 2021 Jun; 10(1):711-727. PubMed ID: 33856660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
